A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
allergic 13 21 13 21 O
reactions 22 31 22 31 O
attributed 32 42 32 42 O
to 43 45 43 45 O
compounds 46 55 46 55 O
of 56 58 56 58 O
similar 59 66 59 66 O
chemical 67 75 67 75 O
or 76 78 76 78 O
biologic 79 87 79 87 O
composition 88 99 88 99 O
to 100 102 100 102 O
PD 103 105 103 105 B-allergy_name
0332991 106 113 106 113 I-allergy_name
, 113 114 113 114 O
cetuximab 115 124 115 124 B-allergy_name
, 124 125 124 125 O
or 126 128 126 128 O
other 129 134 129 134 O
agents 135 141 135 141 O
used 142 146 142 146 O
in 147 149 147 149 O
the 150 153 150 153 O
study 154 159 154 159 O

A 0 1 160 161 O
history 2 9 162 169 O
of 10 12 170 172 O
other 13 18 173 178 O
malignancy 19 29 179 189 B-clinical_variable
≤ 30 31 190 191 O
1 32 33 192 193 B-upper_bound
year 34 38 194 198 I-upper_bound
previous 39 47 199 207 I-upper_bound
with 48 52 208 212 O
the 53 56 213 216 O
exception 57 66 217 226 O
of 67 69 227 229 O
basal 70 75 230 235 B-cancer
cell 76 80 236 240 I-cancer
or 81 83 241 243 O
squamous 84 92 244 252 B-cancer
cell 93 97 253 257 I-cancer
carcinoma 98 107 258 267 I-cancer
of 108 110 268 270 I-cancer
the 111 114 271 274 I-cancer
skin 115 119 275 279 I-cancer
which 120 125 280 285 O
were 126 130 286 290 O
treated 131 138 291 298 O
with 139 143 299 303 O
local 144 149 304 309 B-treatment
resection 150 159 310 319 I-treatment
only 160 164 320 324 O
, 164 165 324 325 O
carcinoma 166 175 326 335 B-cancer
in 176 178 336 338 I-cancer
situ 179 183 339 343 I-cancer
of 184 186 344 346 I-cancer
the 187 190 347 350 I-cancer
cervix 191 197 351 357 I-cancer
, 197 198 357 358 O
or 199 201 359 361 O
synchronous 202 213 362 373 O
H&N 214 217 374 377 O
primaries 218 227 378 387 O

AST 0 3 388 391 B-clinical_variable
( 4 5 392 393 I-clinical_variable
SGOT 5 9 393 397 I-clinical_variable
) 9 10 397 398 I-clinical_variable
and 11 14 399 402 O
ALT 15 18 403 406 B-clinical_variable
( 19 20 407 408 I-clinical_variable
SGPT 20 24 408 412 I-clinical_variable
) 24 25 412 413 I-clinical_variable
≤ 26 27 414 415 O
2.5 28 31 416 419 B-upper_bound
x 32 33 420 421 I-upper_bound
IULN 34 38 422 426 I-upper_bound
for 39 42 427 430 O
patients 43 51 431 439 O
without 52 59 440 447 O
liver 60 65 448 453 B-cancer
metastases 66 76 454 464 I-cancer
and 77 80 465 468 O
≤ 81 82 469 470 O
5.0 83 86 471 474 B-upper_bound
x 87 88 475 476 I-upper_bound
IULN 89 93 477 481 I-upper_bound
for 94 97 482 485 O
patients 98 106 486 494 O
with 107 111 495 499 O
liver 112 117 500 505 O
metastases 118 128 506 516 O

Absolute 0 8 517 525 B-clinical_variable
neutrophil 9 19 526 536 I-clinical_variable
count 20 25 537 542 I-clinical_variable
≥ 26 27 543 544 O
1,500 28 33 545 550 B-lower_bound
mm3 34 37 551 554 I-lower_bound

Alkaline 0 8 555 563 B-clinical_variable
phosphatase 9 20 564 575 I-clinical_variable
≤ 21 22 576 577 O
2.5 23 26 578 581 B-upper_bound
x 27 28 582 583 I-upper_bound
IULN 29 33 584 588 I-upper_bound
for 34 37 589 592 O
patients 38 46 593 601 O
without 47 54 602 609 O
bone 55 59 610 614 B-cancer
metastases 60 70 615 625 I-cancer
and 71 74 626 629 O
≤ 75 76 630 631 O
5.0 77 80 632 635 B-upper_bound
x 81 82 636 637 I-upper_bound
IULN 83 87 638 642 I-upper_bound
for 88 91 643 646 O
patients 92 100 647 655 O
with 101 105 656 660 O
bone 106 110 661 665 O
metastases 111 121 666 676 O

Appropriate 0 11 677 688 O
studies 12 19 689 696 O
will 20 24 697 701 O
be 25 27 702 704 O
undertaken 28 38 705 715 O
in 39 41 716 718 O
patients 42 50 719 727 O
receiving 51 60 728 737 O
combination 61 72 738 749 O
antiretroviral 73 87 750 764 B-treatment
therapy 88 95 765 772 I-treatment
when 96 100 773 777 O
indicated 101 110 778 787 O

Arm 0 3 788 791 O
3 4 5 792 793 O
: 5 6 793 794 O
disease 7 14 795 802 O
must 15 19 803 807 O
be 20 22 808 810 O
HPV 23 26 811 814 B-chronic_disease
- 26 27 814 815 O
related 27 34 815 822 O
SCCHN 35 40 823 828 B-cancer
( 41 42 829 830 O
defined 42 49 830 837 O
as 50 52 838 840 O
OPSCC 53 58 841 846 B-cancer
or 59 61 847 849 O
unknown 62 69 850 857 O
primary 70 77 858 865 O
presenting 78 88 866 876 O
with 89 93 877 881 O
a 94 95 882 883 O
neck 96 100 884 888 O
mass 101 105 889 893 O
that 106 110 894 898 O
is 111 113 899 901 O
either 114 120 902 908 O
p16 121 124 909 912 O
positive 125 133 913 921 O
or 134 136 922 924 O
HPV 137 140 925 928 O
ISH 141 144 929 932 O
or 145 147 933 935 O
PCR 148 151 936 939 O
positive 152 160 940 948 O
) 160 161 948 949 O

Arms 0 4 950 954 O
2 5 6 955 956 O
and 7 10 957 960 O
3 11 12 961 962 O
: 12 13 962 963 O
disease 14 21 964 971 O
progression 22 33 972 983 O
after 34 39 984 989 O
at 40 42 990 992 O
least 43 48 993 998 O
one 49 52 999 1002 B-lower_bound
cycle 53 58 1003 1008 O
of 59 61 1009 1011 O
treatment 62 71 1012 1021 B-treatment
with 72 76 1022 1026 I-treatment
cetuximab 77 86 1027 1036 I-treatment
for 87 90 1037 1040 O
incurable 91 100 1041 1050 O
disease 101 108 1051 1058 O

At 0 2 1059 1061 O
least 3 8 1062 1067 O
18 9 11 1068 1070 B-lower_bound
years 12 17 1071 1076 I-lower_bound
of 18 20 1077 1079 O
age 21 24 1080 1083 B-age

Available 0 9 1084 1093 O
archival 10 18 1094 1102 O
tumor 19 24 1103 1108 B-cancer
tissue 25 31 1109 1115 O
for 32 35 1116 1119 O
the 36 39 1120 1123 O
proposed 40 48 1124 1132 O
correlative 49 60 1133 1144 O
studies 61 68 1145 1152 O

Baseline 0 8 1153 1161 B-clinical_variable
corrected 9 18 1162 1171 I-clinical_variable
QT 19 21 1172 1174 I-clinical_variable
interval 22 30 1175 1183 I-clinical_variable
( 31 32 1184 1185 I-clinical_variable
QTc 32 35 1185 1188 I-clinical_variable
) 35 36 1188 1189 I-clinical_variable
< 37 38 1190 1191 O
480 39 42 1192 1195 B-upper_bound
ms 43 45 1196 1198 I-upper_bound

Currently 0 9 1199 1208 O
receiving 10 19 1209 1218 O
any 20 23 1219 1222 O
other 24 29 1223 1228 O
investigational 30 45 1229 1244 B-treatment
agents 46 52 1245 1251 I-treatment

Drugs 0 5 1252 1257 O
that 6 10 1258 1262 O
are 11 14 1263 1266 O
known 15 20 1267 1272 O
to 21 23 1273 1275 O
prolong 24 31 1276 1283 O
the 32 35 1284 1287 O
QT 36 38 1288 1290 B-clinical_variable
interval 39 47 1291 1299 I-clinical_variable

Drugs 0 5 1300 1305 O
that 6 10 1306 1310 O
are 11 14 1311 1314 O
proton 15 21 1315 1321 B-treatment
pump 22 26 1322 1326 I-treatment
inhibitors 27 37 1327 1337 I-treatment

ECOG 0 4 1338 1342 B-clinical_variable
performance 5 16 1343 1354 I-clinical_variable
status 17 23 1355 1361 I-clinical_variable
≤ 24 25 1362 1363 O
2 26 27 1364 1365 B-upper_bound

Female 0 6 1366 1372 B-gender
patients 7 15 1373 1381 I-gender
must 16 20 1382 1386 O
be 21 23 1387 1389 O
surgically 24 34 1390 1400 O
sterile 35 42 1401 1408 O
or 43 45 1409 1411 O
be 46 48 1412 1414 O
postmenopausal 49 63 1415 1429 O
, 63 64 1429 1430 O
or 65 67 1431 1433 O
must 68 72 1434 1438 O
agree 73 78 1439 1444 B-contraception_consent
to 79 81 1445 1447 I-contraception_consent
use 82 85 1448 1451 I-contraception_consent
effective 86 95 1452 1461 I-contraception_consent
contraceptive 96 109 1462 1475 I-contraception_consent
during 110 116 1476 1482 O
the 117 120 1483 1486 O
period 121 127 1487 1493 O
of 128 130 1494 1496 O
the 131 134 1497 1500 O
trial 135 140 1501 1506 O
and 141 144 1507 1510 O
for 145 148 1511 1514 O
at 149 151 1515 1517 O
least 152 157 1518 1523 O
90 158 160 1524 1526 B-lower_bound
days 161 165 1527 1531 I-lower_bound
after 166 171 1532 1537 O
completion 172 182 1538 1548 O
of 183 185 1549 1551 O
treatment 186 195 1552 1561 B-treatment

Food 0 4 1562 1566 O
or 5 7 1567 1569 O
drugs 8 13 1570 1575 O
that 14 18 1576 1580 O
are 19 22 1581 1584 O
known 23 28 1585 1590 O
to 29 31 1591 1593 O
be 32 34 1594 1596 O
CYP3A4 35 41 1597 1603 B-treatment
inhibitors 42 52 1604 1614 I-treatment
( 53 54 1615 1616 O
e.g. 54 58 1616 1620 O
grapefruit 59 69 1621 1631 O
juice 70 75 1632 1637 O
, 75 76 1637 1638 O
verapamil 77 86 1639 1648 B-treatment
, 86 87 1648 1649 O
ketoconazole 88 100 1650 1662 B-treatment
, 100 101 1662 1663 O
miconazole 102 112 1664 1674 B-treatment
, 112 113 1674 1675 O
itraconazole 114 126 1676 1688 B-treatment
, 126 127 1688 1689 O
erythromycin 128 140 1690 1702 B-treatment
, 140 141 1702 1703 O
clarithromycin 142 156 1704 1718 B-treatment
, 156 157 1718 1719 O
telithromycin 158 171 1720 1733 B-treatment
, 171 172 1733 1734 O
indinavir 173 182 1735 1744 B-treatment
, 182 183 1744 1745 O
ritonavir 184 193 1746 1755 B-treatment
, 193 194 1755 1756 O
nelfinavir 195 205 1757 1767 B-treatment
, 205 206 1767 1768 O
atazanavir 207 217 1769 1779 B-treatment
, 217 218 1779 1780 O
amprenavir 219 229 1781 1791 B-treatment
, 229 230 1791 1792 O
nefazodone 231 241 1793 1803 B-treatment
, 241 242 1803 1804 O
diltiazem 243 252 1805 1814 B-treatment
, 252 253 1814 1815 O
and 254 257 1816 1819 O
delavirdine 258 269 1820 1831 B-treatment
) 269 270 1831 1832 O
or 271 273 1833 1835 O
inducers 274 282 1836 1844 O
( 283 284 1845 1846 O
i.e. 284 288 1846 1850 O
dexamethasone 289 302 1851 1864 B-treatment
, 302 303 1864 1865 O
glucocorticoids 304 319 1866 1881 B-treatment
, 319 320 1881 1882 O
progesterone 321 333 1883 1895 B-treatment
, 333 334 1895 1896 O
rifampin 335 343 1897 1905 B-treatment
, 343 344 1905 1906 O
phenobarbital 345 358 1907 1920 B-treatment
, 358 359 1920 1921 O
St. 360 363 1922 1925 B-treatment
John 364 368 1926 1930 I-treatment
's 368 370 1930 1932 I-treatment
wort 371 375 1933 1937 I-treatment
) 375 376 1937 1938 O

HPV 0 3 1939 1942 B-chronic_disease
- 3 4 1942 1943 O
unrelated 4 13 1943 1952 O
SCCHN 14 19 1953 1958 B-cancer
is 20 22 1959 1961 O
defined 23 30 1962 1969 O
as 31 33 1970 1972 O
either 34 40 1973 1979 O
p16 41 44 1980 1983 O
- 44 45 1983 1984 O
negative 45 53 1984 1992 O
OPSCC 54 59 1993 1998 B-cancer
or 60 62 1999 2001 O
non 63 66 2002 2005 B-cancer
- 66 67 2005 2006 I-cancer
OPSCC 67 72 2006 2011 I-cancer
( 73 74 2012 2013 O
larynx 74 80 2013 2019 O
, 80 81 2019 2020 O
hypopharynx 82 93 2021 2032 O
, 93 94 2032 2033 O
oral 95 99 2034 2038 O
cavity 100 106 2039 2045 O
) 106 107 2045 2046 O
or 108 110 2047 2049 O
p16 111 114 2050 2053 O
- 114 115 2053 2054 O
negative 115 123 2054 2062 O
unknown 124 131 2063 2070 O
primary 132 139 2071 2078 O
SCC 140 143 2079 2082 O
presenting 144 154 2083 2093 O
with 155 159 2094 2098 O
a 160 161 2099 2100 O
level 162 167 2101 2106 B-lower_bound
2 168 169 2107 2108 I-lower_bound
or 170 172 2109 2111 O
3 173 174 2112 2113 B-upper_bound
neck 175 179 2114 2118 O
node 180 184 2119 2123 O
. 184 185 2123 2124 O
p16 186 189 2125 2128 O
will 190 194 2129 2133 O
be 195 197 2134 2136 O
assessed 198 206 2137 2145 O
by 207 209 2146 2148 O
IHC 210 213 2149 2152 O
; 213 214 2152 2153 O
a 215 216 2154 2155 O
specimen 217 225 2156 2164 O
showing 226 233 2165 2172 O
any 234 237 2173 2176 O
staining 238 246 2177 2185 O
will 247 251 2186 2190 O
be 252 254 2191 2193 O
considered 255 265 2194 2204 O
p16 266 269 2205 2208 O
- 269 270 2208 2209 O
positive 270 278 2209 2217 O

Hemoglobin 0 10 2218 2228 B-clinical_variable
> 11 12 2229 2230 O
9 13 14 2231 2232 B-lower_bound
g 15 16 2233 2234 I-lower_bound
/ 16 17 2234 2235 I-lower_bound
dL 17 19 2235 2237 I-lower_bound

Histologically 0 14 2238 2252 O
or 15 17 2253 2255 O
cytologically 18 31 2256 2269 O
confirmed 32 41 2270 2279 O
diagnosis 42 51 2280 2289 O
of 52 54 2290 2292 O
squamous 55 63 2293 2301 B-cancer
cell 64 68 2302 2306 I-cancer
carcinoma 69 78 2307 2316 I-cancer
of 79 81 2317 2319 O
the 82 85 2320 2323 O
head 86 90 2324 2328 O
and 91 94 2329 2332 O
neck 95 99 2333 2337 O

Incurable 0 9 2338 2347 O
is 10 12 2348 2350 O
defined 13 20 2351 2358 O
as 21 23 2359 2361 O
metastatic 24 34 2362 2372 B-cancer
disease 35 42 2373 2380 I-cancer
or 43 45 2381 2383 O
a 46 47 2384 2385 O
local 48 53 2386 2391 O
or 54 56 2392 2394 O
regional 57 65 2395 2403 O
recurrence 66 76 2404 2414 O
in 77 79 2415 2417 O
a 80 81 2418 2419 O
previously 82 92 2420 2430 O
irradiated 93 103 2431 2441 O
site 104 108 2442 2446 O
that 109 113 2447 2451 O
is 114 116 2452 2454 O
unresectable 117 129 2455 2467 O
( 130 131 2468 2469 O
or 131 133 2469 2471 O
patient 134 141 2472 2479 O
declines 142 150 2480 2488 O
resection 151 160 2489 2498 O
) 160 161 2498 2499 O

Measurable 0 10 2500 2510 O
disease 11 18 2511 2518 O
defined 19 26 2519 2526 O
as 27 29 2527 2529 O
lesions 30 37 2530 2537 O
that 38 42 2538 2542 O
can 43 46 2543 2546 O
be 47 49 2547 2549 O
accurately 50 60 2550 2560 O
measured 61 69 2561 2569 O
in 70 72 2570 2572 O
at 73 75 2573 2575 O
least 76 81 2576 2581 O
one 82 85 2582 2585 B-lower_bound
dimension 86 95 2586 2595 O
( 96 97 2596 2597 O
longest 97 104 2597 2604 O
diameter 105 113 2605 2613 O
to 114 116 2614 2616 O
be 117 119 2617 2619 O
recorded 120 128 2620 2628 O
) 128 129 2628 2629 O
as 130 132 2630 2632 O
≥10 133 136 2633 2636 O
mm 137 139 2637 2639 I-lower_bound
with 140 144 2640 2644 O
CT 145 147 2645 2647 B-treatment
scan 148 152 2648 2652 I-treatment
, 152 153 2652 2653 O
as 154 156 2654 2656 O
≥20 157 160 2657 2660 O
mm 161 163 2661 2663 I-lower_bound
by 164 166 2664 2666 O
chest 167 172 2667 2672 O
x 173 174 2673 2674 O
- 174 175 2674 2675 O
ray 175 178 2675 2678 O
, 178 179 2678 2679 O
or 180 182 2680 2682 O
≥10 183 186 2683 2686 O
mm 187 189 2687 2689 O
with 190 194 2690 2694 O
calipers 195 203 2695 2703 B-treatment
by 204 206 2704 2706 O
clinical 207 215 2707 2715 O
exam 216 220 2716 2720 O

Minimum 0 7 2721 2728 O
of 8 10 2729 2731 O
14 11 13 2732 2734 B-upper_bound
days 14 18 2735 2739 I-upper_bound
elapsed 19 26 2740 2747 O
since 27 32 2748 2753 O
the 33 36 2754 2757 O
end 37 40 2758 2761 O
of 41 43 2762 2764 O
any 44 47 2765 2768 O
prior 48 53 2769 2774 B-treatment
therapy 54 61 2775 2782 I-treatment

Patient 0 7 2783 2790 O
must 8 12 2791 2795 O
not 13 16 2796 2799 O
have 17 21 2800 2804 O
a 22 23 2805 2806 O
history 24 31 2807 2814 O
of 32 34 2815 2817 O
or 35 37 2818 2820 O
clinical 38 46 2821 2829 O
evidence 47 55 2830 2838 O
of 56 58 2839 2841 O
central 59 66 2842 2849 B-cancer
nervous 67 74 2850 2857 I-cancer
system 75 81 2858 2864 I-cancer
metastases 82 92 2865 2875 I-cancer
or 93 95 2876 2878 O
leptomeningeal 96 110 2879 2893 B-cancer
carcinomatosis 111 125 2894 2908 I-cancer

Phase 0 5 2909 2914 O
I 6 7 2915 2916 O
and 8 11 2917 2920 O
Arm 12 15 2921 2924 O
1 16 17 2925 2926 O
of 18 20 2927 2929 O
Phase 21 26 2930 2935 O
II 27 29 2936 2938 O
: 29 30 2938 2939 O
Known 31 36 2940 2945 O
HIV 37 40 2946 2949 B-chronic_disease
- 40 41 2949 2950 O
positivity 41 51 2950 2960 O
and 52 55 2961 2964 O
on 56 58 2965 2967 O
combination 59 70 2968 2979 O
antiretroviral 71 85 2980 2994 B-treatment
therapy 86 93 2995 3002 I-treatment
because 94 101 3003 3010 O
of 102 104 3011 3013 O
the 105 108 3014 3017 O
potential 109 118 3018 3027 O
for 119 122 3028 3031 O
pharmacokinetic 123 138 3032 3047 B-treatment
interactions 139 151 3048 3060 I-treatment
with 152 156 3061 3065 I-treatment
PD 157 159 3066 3068 I-treatment
0332991 160 167 3069 3076 I-treatment

Phase 0 5 3077 3082 O
I 6 7 3083 3084 O
only 8 12 3085 3089 O
: 12 13 3089 3090 O
any 14 17 3091 3094 O
( 18 19 3095 3096 O
or 19 21 3096 3098 O
no 22 24 3099 3101 O
) 24 25 3101 3102 O
prior 26 31 3103 3108 B-treatment
therapy 32 39 3109 3116 I-treatment
for 40 43 3117 3120 O
metastatic 44 54 3121 3131 B-cancer
disease 55 62 3132 3139 I-cancer
is 63 65 3140 3142 O
allowed 66 73 3143 3150 O
, 73 74 3150 3151 O
including 75 84 3152 3161 O
cetuximab 85 94 3162 3171 B-treatment

Phase 0 5 3172 3177 O
II 6 8 3178 3180 O
, 8 9 3180 3181 O
Arm 10 13 3182 3185 O
1 14 15 3186 3187 O
only 16 20 3188 3192 O
: 20 21 3192 3193 O
prior 22 27 3194 3199 B-treatment
treatment 28 37 3200 3209 I-treatment
with 38 42 3210 3214 O
cetuximab 43 52 3215 3224 B-treatment

Platelets 0 9 3225 3234 B-clinical_variable
≥ 10 11 3235 3236 O
100,000 12 19 3237 3244 B-lower_bound
mm3 20 23 3245 3248 I-lower_bound

Pregnant 0 8 3249 3257 B-pregnancy
and/or 9 15 3258 3264 O
breastfeeding 16 29 3265 3278 O
. 29 30 3278 3279 O
Women 31 36 3280 3285 B-gender
of 37 39 3286 3288 O
childbearing 40 52 3289 3301 O
potential 53 62 3302 3311 O
must 63 67 3312 3316 O
have 68 72 3317 3321 O
a 73 74 3322 3323 O
negative 75 83 3324 3332 B-pregnancy
serum 84 89 3333 3338 I-pregnancy
pregnancy 90 99 3339 3348 I-pregnancy
test 100 104 3349 3353 O
within 105 111 3354 3360 O
28 112 114 3361 3363 B-upper_bound
days 115 119 3364 3368 I-upper_bound
of 120 122 3369 3371 O
study 123 128 3372 3377 O
entry 129 134 3378 3383 O

Prior 0 5 3384 3389 B-treatment
treatment 6 15 3390 3399 I-treatment
with 16 20 3400 3404 I-treatment
cetuximab 21 30 3405 3414 I-treatment
for 31 34 3415 3418 O
incurable 35 44 3419 3428 O
disease 45 52 3429 3436 O
is 53 55 3437 3439 O
not 56 59 3440 3443 O
permitted 60 69 3444 3453 O

Resolution 0 10 3454 3464 O
of 11 13 3465 3467 O
all 14 17 3468 3471 O
acute 18 23 3472 3477 O
toxic 24 29 3478 3483 O
effects 30 37 3484 3491 O
of 38 40 3492 3494 O
prior 41 46 3495 3500 B-treatment
anti 47 51 3501 3505 I-treatment
- 51 52 3505 3506 I-treatment
cancer 52 58 3506 3512 I-treatment
therapy 59 66 3513 3520 I-treatment
or 67 69 3521 3523 O
surgical 70 78 3524 3532 B-treatment
procedures 79 89 3533 3543 I-treatment
to 90 92 3544 3546 O
NCI 93 96 3547 3550 B-clinical_variable
CTCAE 97 102 3551 3556 I-clinical_variable
version 103 110 3557 3564 I-clinical_variable
4.0 111 114 3565 3568 I-clinical_variable
Grade 115 120 3569 3574 I-clinical_variable
≤ 121 122 3575 3576 O
1 123 124 3577 3578 B-upper_bound

Resolution 0 10 3579 3589 O
of 11 13 3590 3592 O
all 14 17 3593 3596 O
acute 18 23 3597 3602 O
toxic 24 29 3603 3608 O
effects 30 37 3609 3616 O
of 38 40 3617 3619 O
prior 41 46 3620 3625 B-treatment
anti 47 51 3626 3630 I-treatment
- 51 52 3630 3631 I-treatment
cancer 52 58 3631 3637 I-treatment
therapy 59 66 3638 3645 I-treatment
or 67 69 3646 3648 O
surgical 70 78 3649 3657 B-treatment
procedures 79 89 3658 3668 I-treatment
to 90 92 3669 3671 O
NCI 93 96 3672 3675 B-clinical_variable
CTCAE 97 102 3676 3681 I-clinical_variable
version 103 110 3682 3689 I-clinical_variable
4.0 111 114 3690 3693 I-clinical_variable
Grade 115 120 3694 3699 I-clinical_variable
≤ 121 122 3700 3701 O
1 123 124 3702 3703 B-upper_bound
( 125 126 3704 3705 O
except 126 132 3705 3711 O
alopecia 133 141 3712 3720 B-chronic_disease
or 142 144 3721 3723 O
other 145 150 3724 3729 O
toxicities 151 161 3730 3740 O
not 162 165 3741 3744 O
considered 166 176 3745 3755 O
a 177 178 3756 3757 O
safety 179 185 3758 3764 O
risk 186 190 3765 3769 O
for 191 194 3770 3773 O
the 195 198 3774 3777 O
patient 199 206 3778 3785 O
at 207 209 3786 3788 O
investigator 210 222 3789 3801 O
's 222 224 3801 3803 O
discretion 225 235 3804 3814 O
) 235 236 3814 3815 O

Serum 0 5 3816 3821 B-clinical_variable
creatinine 6 16 3822 3832 I-clinical_variable
≤ 17 18 3833 3834 O
1.5 19 22 3835 3838 B-upper_bound
x 23 24 3839 3840 I-upper_bound
IULN 25 29 3841 3845 I-upper_bound
OR 30 32 3846 3848 O
calculated 33 43 3849 3859 B-lower_bound
creatinine 44 54 3860 3870 I-lower_bound
clearance 55 64 3871 3880 I-lower_bound
≥ 65 66 3881 3882 O
50 67 69 3883 3885 B-lower_bound
mL 70 72 3886 3888 I-lower_bound
/ 72 73 3888 3889 I-lower_bound
min/1.73 73 81 3889 3897 I-lower_bound
m2 82 84 3898 3900 I-lower_bound
for 85 88 3901 3904 O
patients 89 97 3905 3913 O
with 98 102 3914 3918 O
creatinine 103 113 3919 3929 B-clinical_variable
levels 114 120 3930 3936 I-clinical_variable
above 121 126 3937 3942 O
institutional 127 140 3943 3956 O
normal 141 147 3957 3963 O

Should 0 6 3964 3970 O
a 7 8 3971 3972 O
woman 9 14 3973 3978 B-gender
become 15 21 3979 3985 B-pregnancy
pregnant 22 30 3986 3994 I-pregnancy
or 31 33 3995 3997 O
suspect 34 41 3998 4005 O
she 42 45 4006 4009 O
is 46 48 4010 4012 O
pregnant 49 57 4013 4021 O
while 58 63 4022 4027 O
participating 64 77 4028 4041 O
in 78 80 4042 4044 O
this 81 85 4045 4049 O
study 86 91 4050 4055 O
, 91 92 4055 4056 O
she 93 96 4057 4060 O
must 97 101 4061 4065 O
inform 102 108 4066 4072 O
her 109 112 4073 4076 O
treating 113 121 4077 4085 O
physician 122 131 4086 4095 O
immediately 132 143 4096 4107 O

Total 0 5 4108 4113 B-clinical_variable
bilirubin 6 15 4114 4123 I-clinical_variable
≤ 16 17 4124 4125 O
1.5 18 21 4126 4129 B-upper_bound
x 22 23 4130 4131 I-upper_bound
IULN 24 28 4132 4136 I-upper_bound
except 29 35 4137 4143 O
in 36 38 4144 4146 O
the 39 42 4147 4150 O
case 43 47 4151 4155 O
of 48 50 4156 4158 O
patients 51 59 4159 4167 O
with 60 64 4168 4172 O
Gilbert 65 72 4173 4180 B-chronic_disease
's 72 74 4180 4182 I-chronic_disease
disease 75 82 4183 4190 I-chronic_disease

Treated 0 7 4191 4198 O
within 8 14 4199 4205 O
the 15 18 4206 4209 O
last 19 23 4210 4214 B-upper_bound
7 24 25 4215 4216 I-upper_bound
days 26 30 4217 4221 I-upper_bound
prior 31 36 4222 4227 I-upper_bound
to 37 39 4228 4230 O
Day 40 43 4231 4234 O
1 44 45 4235 4236 O
of 46 48 4237 4239 O
protocol 49 57 4240 4248 O
therapy 58 65 4249 4256 B-treatment

Uncontrolled 0 12 4257 4269 O
electrolyte 13 24 4270 4281 B-chronic_disease
disorders 25 34 4282 4291 I-chronic_disease
that 35 39 4292 4296 O
can 40 43 4297 4300 O
compound 44 52 4301 4309 O
the 53 56 4310 4313 O
effects 57 64 4314 4321 O
of 65 67 4322 4324 O
a 68 69 4325 4326 O
QTc 70 73 4327 4330 B-treatment
- 73 74 4330 4331 I-treatment
prolonging 74 84 4331 4341 I-treatment
drug 85 89 4342 4346 I-treatment
( 90 91 4347 4348 O
e.g. 91 95 4348 4352 O
, 95 96 4352 4353 O
hypocalcemia 97 109 4354 4366 B-chronic_disease
, 109 110 4366 4367 O
hypokalemia 111 122 4368 4379 B-chronic_disease
, 122 123 4379 4380 O
hypomagnesemia 124 138 4381 4395 B-chronic_disease
) 138 139 4395 4396 O

Uncontrolled 0 12 4397 4409 O
intercurrent 13 25 4410 4422 O
illness 26 33 4423 4430 O
including 34 43 4431 4440 O
, 43 44 4440 4441 O
but 45 48 4442 4445 O
not 49 52 4446 4449 O
limited 53 60 4450 4457 O
to 61 63 4458 4460 O
, 63 64 4460 4461 O
ongoing 65 72 4462 4469 O
or 73 75 4470 4472 O
active 76 82 4473 4479 B-chronic_disease
infection 83 92 4480 4489 I-chronic_disease
symptomatic 93 104 4490 4501 O
congestive 105 115 4502 4512 B-chronic_disease
heart 116 121 4513 4518 I-chronic_disease
failure 122 129 4519 4526 I-chronic_disease
, 129 130 4526 4527 O
unstable 131 139 4528 4536 B-chronic_disease
angina 140 146 4537 4543 I-chronic_disease
pectoris 147 155 4544 4552 I-chronic_disease
, 155 156 4552 4553 O
cardiac 157 164 4554 4561 B-chronic_disease
arrhythmia 165 175 4562 4572 I-chronic_disease
, 175 176 4572 4573 O
or 177 179 4574 4576 O
psychiatric 180 191 4577 4588 B-chronic_disease
illness 192 199 4589 4596 I-chronic_disease
/ 199 200 4596 4597 I-chronic_disease
social 200 206 4597 4603 I-chronic_disease
situations 207 217 4604 4614 I-chronic_disease
that 218 222 4615 4619 O
would 223 228 4620 4625 O
limit 229 234 4626 4631 O
compliance 235 245 4632 4642 O
with 246 250 4643 4647 O
study 251 256 4648 4653 O
requirements 257 269 4654 4666 O

Women 0 5 4667 4672 B-gender
of 6 8 4673 4675 O
childbearing 9 21 4676 4688 O
potential 22 31 4689 4698 O
and 32 35 4699 4702 O
men 36 39 4703 4706 O
must 40 44 4707 4711 O
agree 45 50 4712 4717 B-contraception_consent
to 51 53 4718 4720 I-contraception_consent
use 54 57 4721 4724 I-contraception_consent
adequate 58 66 4725 4733 I-contraception_consent
contraception 67 80 4734 4747 I-contraception_consent
( 81 82 4748 4749 O
hormonal 82 90 4749 4757 B-contraception_consent
or 91 93 4758 4760 O
barrier 94 101 4761 4768 B-contraception_consent
method 102 108 4769 4775 I-contraception_consent
of 109 111 4776 4778 I-contraception_consent
birth 112 117 4779 4784 I-contraception_consent
control 118 125 4785 4792 I-contraception_consent
, 125 126 4792 4793 O
abstinence 127 137 4794 4804 B-contraception_consent
) 137 138 4804 4805 O
prior 139 144 4806 4811 O
to 145 147 4812 4814 O
study 148 153 4815 4820 O
entry 154 159 4821 4826 O
and 160 163 4827 4830 O
for 164 167 4831 4834 O
the 168 171 4835 4838 O
duration 172 180 4839 4847 O
of 181 183 4848 4850 O
study 184 189 4851 4856 O
participation 190 203 4857 4870 O

alopecia 0 8 4871 4879 B-chronic_disease
or 9 11 4880 4882 O
other 12 17 4883 4888 O
toxicities 18 28 4889 4899 O
not 29 32 4900 4903 O
considered 33 43 4904 4914 O
a 44 45 4915 4916 O
safety 46 52 4917 4923 O
risk 53 57 4924 4928 O
for 58 61 4929 4932 O
the 62 65 4933 4936 O
patient 66 73 4937 4944 O
at 74 76 4945 4947 O
investigator´s 77 91 4948 4962 O
discretion 92 102 4963 4973 O

disease 0 7 4974 4981 O
must 8 12 4982 4986 O
be 13 15 4987 4989 O
determined 16 26 4990 5000 O
to 27 29 5001 5003 O
be 30 32 5004 5006 O
HPV 33 36 5007 5010 B-chronic_disease
- 36 37 5010 5011 O
unrelated 37 46 5011 5020 O

individuals 0 11 5021 5032 O
who 12 15 5033 5036 O
have 16 20 5037 5041 O
had 21 24 5042 5045 O
previously 25 35 5046 5056 O
- 35 36 5056 5057 O
treated 36 43 5057 5064 O
CNS 44 47 5065 5068 B-cancer
metastases 48 58 5069 5079 I-cancer
, 58 59 5079 5080 O
are 60 63 5081 5084 O
asymptomatic 64 76 5085 5097 O
, 76 77 5097 5098 O
and 78 81 5099 5102 O
have 82 86 5103 5107 O
had 87 90 5108 5111 O
no 91 93 5112 5114 O
requirement 94 105 5115 5126 O
for 106 109 5127 5130 O
steroids 110 118 5131 5139 B-treatment
or 119 121 5140 5142 O
anti 122 126 5143 5147 B-treatment
- 126 127 5147 5148 I-treatment
seizure 127 134 5148 5155 I-treatment
medications 135 146 5156 5167 I-treatment
( 147 148 5168 5169 O
with 148 152 5169 5173 O
the 153 156 5174 5177 O
exception 157 166 5178 5187 O
of 167 169 5188 5190 O
Keppra 170 176 5191 5197 B-treatment
) 176 177 5197 5198 O
for 178 181 5199 5202 O
1 182 183 5203 5204 B-upper_bound
month 184 189 5205 5210 I-upper_bound
prior 190 195 5211 5216 I-upper_bound
to 196 198 5217 5219 O
first 199 204 5220 5225 O
dose 205 209 5226 5230 O
of 210 212 5231 5233 O
PD 213 215 5234 5236 B-treatment
0332991 216 223 5237 5244 I-treatment

patients 0 8 5245 5253 O
with 9 13 5254 5258 O
HIV 14 17 5259 5262 B-chronic_disease
infection 18 27 5263 5272 I-chronic_disease
and 28 31 5273 5276 O
antiretroviral 32 46 5277 5291 B-treatment
therapy 47 54 5292 5299 I-treatment
are 55 58 5300 5303 O
not 59 62 5304 5307 O
excluded 63 71 5308 5316 O
, 71 72 5316 5317 O
as 73 75 5318 5320 O
there 76 81 5321 5326 O
are 82 85 5327 5330 O
no 86 88 5331 5333 O
pharmacokinetic 89 104 5334 5349 B-treatment
tests 105 110 5350 5355 O
being 111 116 5356 5361 O
performed 117 126 5362 5371 O

these 0 5 5372 5377 O
patients 6 14 5378 5386 O
are 15 18 5387 5390 O
at 19 21 5391 5393 O
increased 22 31 5394 5403 O
risk 32 36 5404 5408 O
of 37 39 5409 5411 O
lethal 40 46 5412 5418 B-chronic_disease
infections 47 57 5419 5429 I-chronic_disease
when 58 62 5430 5434 O
treated 63 70 5435 5442 O
with 71 75 5443 5447 O
marrow 76 82 5448 5454 B-treatment
- 82 83 5454 5455 I-treatment
suppressive 83 94 5455 5466 I-treatment
therapy 95 102 5467 5474 I-treatment

